rs748849525

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 2P and 12B. PM4BP6_Very_StrongBS2

The NM_021072.4(HCN1):​c.200_223delGTGGCGGCGGCGGCGGCGGCGGCG​(p.Gly67_Gly74del) variant causes a disruptive inframe deletion change. The variant allele was found at a frequency of 0.0000256 in 1,563,470 control chromosomes in the GnomAD database, including 1 homozygotes. It is difficult to determine the true allele frequency of this variant because it is of type DEL_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. G67G) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000014 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000027 ( 1 hom. )

Consequence

HCN1
NM_021072.4 disruptive_inframe_deletion

Scores

Not classified

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 6.52

Publications

0 publications found
Variant links:
Genes affected
HCN1 (HGNC:4845): (hyperpolarization activated cyclic nucleotide gated potassium channel 1) The membrane protein encoded by this gene is a hyperpolarization-activated cation channel that contributes to the native pacemaker currents in heart and neurons. The encoded protein can homodimerize or heterodimerize with other pore-forming subunits to form a potassium channel. This channel may act as a receptor for sour tastes. [provided by RefSeq, Oct 2011]
HCN1 Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 24
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • generalized epilepsy with febrile seizures plus
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • generalized epilepsy with febrile seizures plus, type 10
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

PM4
Nonframeshift variant in NON repetitive region in NM_021072.4.
BP6
Variant 5-45695870-TCGCCGCCGCCGCCGCCGCCGCCAC-T is Benign according to our data. Variant chr5-45695870-TCGCCGCCGCCGCCGCCGCCGCCAC-T is described in ClinVar as [Likely_benign]. Clinvar id is 461368.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAdExome4 at 38 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HCN1NM_021072.4 linkc.200_223delGTGGCGGCGGCGGCGGCGGCGGCG p.Gly67_Gly74del disruptive_inframe_deletion Exon 1 of 8 ENST00000303230.6 NP_066550.2 O60741Q86WJ6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HCN1ENST00000303230.6 linkc.200_223delGTGGCGGCGGCGGCGGCGGCGGCG p.Gly67_Gly74del disruptive_inframe_deletion Exon 1 of 8 1 NM_021072.4 ENSP00000307342.4 O60741
HCN1ENST00000673735.1 linkc.200_223delGTGGCGGCGGCGGCGGCGGCGGCG p.Gly67_Gly74del disruptive_inframe_deletion Exon 1 of 9 ENSP00000501107.1 A0A669KB45
HCN1ENST00000634658.1 linkc.200_223delGTGGCGGCGGCGGCGGCGGCGGCG p.Gly67_Gly74del disruptive_inframe_deletion Exon 1 of 2 3 ENSP00000489134.1 A0A0U1RQR7
HCN1ENST00000638054.1 linkn.-169_-146delGTGGCGGCGGCGGCGGCGGCGGCG upstream_gene_variant 5

Frequencies

GnomAD3 genomes
AF:
0.0000135
AC:
2
AN:
147994
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000133
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000195
AC:
32
AN:
164440
AF XY:
0.000150
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00135
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000837
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000268
AC:
38
AN:
1415358
Hom.:
1
AF XY:
0.0000256
AC XY:
18
AN XY:
702546
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31432
American (AMR)
AF:
0.000943
AC:
37
AN:
39240
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24940
East Asian (EAS)
AF:
0.0000264
AC:
1
AN:
37864
South Asian (SAS)
AF:
0.00
AC:
0
AN:
81870
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
41108
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5298
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1095106
Other (OTH)
AF:
0.00
AC:
0
AN:
58500
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.713
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000135
AC:
2
AN:
148112
Hom.:
0
Cov.:
32
AF XY:
0.0000138
AC XY:
1
AN XY:
72348
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
40302
American (AMR)
AF:
0.000133
AC:
2
AN:
15028
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3420
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4858
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4618
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10108
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
264
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
66570
Other (OTH)
AF:
0.00
AC:
0
AN:
2058
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.575
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000529

ClinVar

Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Inborn genetic diseases Benign:1
Oct 17, 2016
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Developmental and epileptic encephalopathy Benign:1
Dec 02, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
6.5
Mutation Taster
=194/6
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs748849525; hg19: chr5-45695972; API